Integrated BioPharma, Inc.

Entry into a Material Definitive Agreement. On February 17, 2026, Manhattan Drug Company, Inc. ("MDC"), a wholly owned subsidiary of Integrated Biopharma Inc. (the "Company”), entered into a Fourth Amendment of Lease (the "Amendment") with Vitamin Realty Associates, LLC ("Vitamin Realty") to that certain Lease Agreement dated January 10, 1997, as amended on July 15, 2022 (the "Original Lease") with respect to certain office and warehouse space leased by MDC from Vitamin Realty. The Amendment (i) decreases the total square footage MDC is leasing from Vitamin Realty from 116,175 square feet to 110,095 square feet, (ii) increases the annual basic rent amounts from $845,966 to $1,100,950 per annum, increasing three percent (3%) per annum, and extends the Termination Date to January 31, 2029. In addition to the annual basic rent amounts, MDC will be obligated to pay its proportionate share of Vitamin Realty's operating expenses as additional rent. All other terms of the Original Lease, as originally amended, remain in full force. Vitamin Realty is 100% owned by the estate of Company's former chairman, and a major stockholder and the Co-Chief Executive Officers, who are also Directors of the Company.